Multiple Sclerosis: Hope Through New Oral Therapeutics
Main Category: Multiple SclerosisAlso Included In: Neurology / Neuroscience
Article Date: 23 Jun 2009 - 2:00 PDT
email to a friend 
printer friendly 
opinions
| Patient / Public: |  |
3.38 (8 votes) |
| Healthcare Prof: | |
3.5 (2 votes) |
"The immunomodulating and immunosuppressive therapies for multiple sclerosis available today are only partially effective. We need a better use of the existing therapies - inter alia through early treatment and innovative approaches - in order to more efficiently help our patients," says Professor Giancarlo Comi of Milan, Italy, Chairperson of the meeting of the European Neurological Society (ENS) currently held in his home town. This major meeting in European neurology gathers more than 2,900 experts from all over the world. Professor Comi: "One interesting development involves new drugs highly active that can be taken orally."
More than 400,000 people in Europe suffer from multiple sclerosis (MS), the most common neurological disease leading to permanent disability in young adults. MS attacks the central nervous system and is considered an auto-immune disease, but other possible causes are also under discussion. "Multiple sclerosis is still not curable. A number of new findings have been made in recent years with regard to the origins of the disease and new therapeutic strategies," says Professor Comi. "These new insights can help us to mitigate the course of the disease and delay the development of permanent disabilities. Moreover some new treatments which will be available soon will enhance the possibility to control the disease evolution, opening new positive perspectives for patients."
Source
European Neurological Society
Visit our multiple sclerosis section for the latest news on this subject.
MLA
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/154917.php>
APA
http://www.medicalnewstoday.com/releases/154917.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
Privacy Policy |
Terms and Conditions
MediLexicon International Ltd
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2012 All rights reserved.
